|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
06606 NH HEALTH
Nominal 
14.140 0.000 (0.000%) | 2023/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Turnover | 822,675 | 264.577% | 764,960 | 212,761 | 70,567 | 58,275 |
| Cost of Sales | (75,174) | 85.322% | (118,790) | (58,116) | (33,318) | (23,957) |
| Gross Profit | 747,501 | 303.862% | 646,170 | 154,645 | 37,249 | 34,318 |
| 2023/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | (19,217) | (26,900) | (338) | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 11,965 | -- | (79,658) | (3,085,336) | (788,421) | (106,235) | |
| Taxation | 113,378 | -- | (655) | 0 | (303) | (230) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 311 | -- | 1,075 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 125,654 | -- | (79,238) | (3,085,336) | (788,724) | (106,465) | |
| 2023/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 5,687 | 62.069% | (5,158) | (8,596) | 3,612 | (592) |
| Depreciation & Amortisation | 19,207 | 63.186% | 26,326 | 19,274 | 14,874 | 13,378 |
| Directors' Emoluments | -- | -- | 60,665 | 24,987 | 16,455 | 11,311 |
| 2023/06 - Interim | %Chg (Compare to Interim) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2023/06 - Interim | %Chg (Compare to Interim) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | 26.000 | -- | -19.000 | -815.000 | -664.000 | -92.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | (0.975) | (0.937) | (1.114) | (0.651) |
| NBV per share ($) | 6.525 | -- | 4.934 | 4.949 | -- | -- |
| Remarks: | Real time quote last updated: 27/11/2024 09:01 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB 125,654,000 |
| %Change | -- |
| EPS / (LPS) | RMB 0.260 |
| NBV Per Share (¥) | RMB 6.525 |